Table 2.
Gene Ontology of vFLIP K13 affected genes.
| S. No. | Molecular Function and Disease | p-value | Genes(n) |
| 1 | Immune Response | 5.18E-22 - 1.76E-05 | 63 |
| 2 | Cellular Movement | 8.19E-19 - 1.83E-05 | 50 |
| 3 | Inflammatory Disease | 8.38E-16 - 1.22E-05 | 37 |
| 4 | Hematological System Development and Function | 8.94E-16 - 1.83E-05 | 53 |
| 5 | Cancer | 2.64E-15 - 1.83E-05 | 73 |
| 6 | Cell-To-Cell Signaling and Interaction | 3.71E-15 - 1.83E-05 | 47 |
| 7 | Tissue Morphology | 2.98E-14 - 9.68E-06 | 33 |
| 8 | Immune and Lymphatic System Development and Function | 2.68E-13 - 1.76E-05 | 44 |
| 9 | Connective Tissues Disorders | 3.99E-13 - 7.43E-06 | 21 |
| 10 | Skeletal and Muscular Disorders | 3.99E-13 - 7.43E-06 | 24 |
| 11 | Cellular Growth and Proliferation | 1.64E-12 - 1.45E-05 | 73 |
| 12 | Cell death | 1.27E-11 - 1.87E-05 | 52 |
| 13 | Immunological Disease | 2.47E-09 - 1.87E-05 | 32 |
| 14 | Tissue Development | 4.14E-11 - 1.76E-05 | 51 |
| 15 | Cell Signaling | 1.73E-10 - 7.56E-06 | 71 |
| 16 | Cellular Development | 3.41E-10 - 1.70E-05 | 32 |
| 17 | Hematological Disease | 4.29E-10 - 1.79E-05 | 39 |
| 18 | Neurological Disease | 2.34E-09 - 1.83E-05 | 8 |
| 19 | Cell Cycle | 4.54E-09 - 1.44E-05 | 7 |
| 20 | Respiratory Disease | 3.20E-08 - 1.61E-06 | 14 |
| 21 | Viral Function | 3.29E-08 - 3.29E-08 | 11 |